Children's Hospital St. Elisabeth in Neuburg/Donau Installs Masimo Patient SafetyNet(TM) System for Advanced Care and Oversight of General Ward Patients

December 19, 2013

NEUBURG, GERMANY and IRVINE, CA -- (Marketwired) -- 12/19/13 -- Children's Hospital St. Elisabeth in Neuburg, and Masimo (NASDAQ: MASI) today announced that the hospital installed the largest Patient SafetyNet™ system in Germany. Patient SafetyNet is a remote monitoring and clinician notification system shown to keep patients safer, enabling a 65% reduction in rapid response team activations and 48% reduction in ICU transfers.1

The installation includes Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry technology, proven by more than 100 independent and objective studies and used on an estimated 100 million patients a year in leading hospitals worldwide, as well as rainbow® Acoustic Monitoring (RAM™), a breakthrough respiration rate (RRa) measurement used with a cloth adhesive sensor worn on the neck that allows clinicians to noninvasively and continuously assess patients' breathing, facilitating earlier detection of respiratory compromise and patient distress.

Carmen Bauer, head nurse of ward 15 at the Children's Hospital, stated: "With Masimo Patient SafetyNet covering 40 beds on two general children wards, we are now able to feel absolutely safe for our patients. We have observed that it's especially beneficial for our most vulnerable patients, who potentially suffer from respiratory depression. And, our staff has been extremely satisfied with the system."

St. Elisabeth joins a growing list of hospitals around the world using Patient SafetyNet, which leverages the performance of Masimo SET® pulse oximetry. Compared to other pulse oximeters during patient motion and low perfusion, Masimo SET® provides measurements when other pulse oximeters cannot, significantly reduces false alarms (specificity), and accurately detects true alarms (sensitivity)2,3 that can help clinicians identify a deteriorating patient. Most importantly, Masimo SET® pulse oximetry is the only technology clinically proven to improve patient outcomes by helping clinicians reduce retinopathy of prematurity (ROP)4 in neonates, screen newborns for critical congenital heart disease (CCHD),5,6 reduce ventilator weaning time and arterial blood gas measurements in the ICU,7 and save lives and costs while reducing rapid response activations and intensive care unit transfers on the general floor.3

Patient SafetyNet can help ensure patients' safety by noninvasively and continuously measuring and tracking their underlying physiological conditions and detecting changes or abnormalities in vital sign measurements that may signal declining health status in real-time. When changes occur in the measured values, which may indicate deterioration in the patient's condition, the system automatically sends wireless alerts directly to clinicians -- prompting a potentially lifesaving response to the patient's bedside.

1 Taenzer A, Blike G, McGrath S, Pyke J, Herrick M, Renaud C, Morgan J. "Postoperative Monitoring - The Dartmouth Experience." Anesthesia Patient Safety Foundation Newsletter Spring-Summer 2012. Available online
2 Shah N, Ragaswamy HB, Govindugari K, Estanol L "Performance of Three New-Generation Pulse Oximeters during Motion and Low Perfusion in Volunteers".J Clin Anesth. 2012 Aug;24(5):385-91.
3 Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan P.; Blike, George T. "Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study." Anesthesiology, February 2010, Vol. 112, Issue 2. Available online here.
4 Castillo A, et al. Acta Paediatr. 2011 Feb.;100(2):188-92.
5 de-Wahl Granelli A., et al. BMJ. 2009 Jan 8;338.
6 Ewer A, et al. Health Technol Assess. 2012;16(2):1-184.
7 Durbin, et al. Critical Care Mezxdicine. 2002 Aug.;30(8): 1735 to 1740.

About St. Elisabeth Children's Hospital in Neuburg
St. Elisabeth was built out of three hospitals with 321 beds in total and has a history starting in 1840. The children's hospital has been awarded twice for excellence in Children Care. For more information, visit

About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care -- helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously required invasive procedures, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at

Forward Looking Statements
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions that Masimo Patient SafetyNet can help keep patients safer by noninvasively, continuously measuring and tracking their underlying physiological condition to help hospitals avoid preventable patient deaths and injuries associated with failure to rescue events, risks related to our assumptions of the repeatability of clinical results obtained, and risks related to the system's ability to significantly decrease traumatic critical events and costly ICU transfers to help improve patient outcomes and reduce costs; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter, Adaptive Threshold Alarm, and SEDLine are trademarks or registered trademarks of Masimo Corporation. The use of the trademarks Patient SafetyNet and PSN is under license from University HealthSystem Consortium.

Media Contacts:
Kinderklinik St. Elisabeth
Thomas Bauch
Phone: +49 8431 541190

Masimo Corporation
Mike Drummond
(949) 297-7434

Source: Masimo